EP Patent

EP0596161A1 — Apparatus for subcutaneous introduction of a needle

Assigned to Texas Instruments Holland BV · Expires 1994-05-11 · 32y expired

What this patent protects

Apparatus for subcutaneous introduction of a needle (2) in a living being. This needle (2) has to be placed substantially tangentially to the skin of said living being immediately under the skin during all of the needle introduction movement. Guiding means (4,5) are provided to g…

USPTO Abstract

Apparatus for subcutaneous introduction of a needle (2) in a living being. This needle (2) has to be placed substantially tangentially to the skin of said living being immediately under the skin during all of the needle introduction movement. Guiding means (4,5) are provided to guarantee the position of the needle (2) parallel to the skin. This guiding means (4,5) comprise two guiding members at both sides of the needle. The guiding members extend substantially parallel to the needle (2) and the point of external contact with the skin is at least level with the upper part of the needle. This means that the skin is folded between the guiding members and the needle.

Drugs covered by this patent

Patent Metadata

Patent number
EP0596161A1
Jurisdiction
EP
Classification
Expires
1994-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Texas Instruments Holland BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.